Organon to acquire Dermavant for $1.2bn, expanding its presence in immuno-dermatology
Organon, a global healthcare company focused on women’s health, has announced a definitive agreement to acquire Dermavant Sciences Ltd., a Roivant company specialising in immuno-dermatology, in a deal valued at up to $1.2 billion. This acquisition marks a significant step in Organon’s strategy to expand its portfolio, particularly in dermatology, where Dermavant has made strides […]